P20—Agalsidase Beta Treatment is Associated With Improvement in Quality of Life in Patients With Fabry Disease: Findings From the Fabry Registry.
Saved in:
| Title: | P20—Agalsidase Beta Treatment is Associated With Improvement in Quality of Life in Patients With Fabry Disease: Findings From the Fabry Registry. |
|---|---|
| Authors: | Feldt-Rasmussen, U. (AUTHOR), Watt, T. (AUTHOR), Burlina, A.P. (AUTHOR), Cazzorla, C. (AUTHOR), Schönfeld, D. (AUTHOR), Banikazemi, M. (AUTHOR), Hopkin, R.J. (AUTHOR), Martins, A.M. (AUTHOR), Sims, K. (AUTHOR), Beitner-Johnson, D. (AUTHOR), O'Brien, F. (AUTHOR) |
| Source: | Clinical Therapeutics. Apr2012 Supplement, Vol. 34, pe26-e26. 1p. |
| URL: | 74553606 |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
